Viewing Study NCT00919035


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2026-01-02 @ 9:38 PM
Study NCT ID: NCT00919035
Status: COMPLETED
Last Update Posted: 2014-06-30
First Post: 2009-06-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients
Sponsor: Oncology Specialists, S.C.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostate cancer View
None androgen-independent prostate cancer (AIPC) Prostate Cancer View